Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1991
10/31/1991WO1991016048A1 2(5H)-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS
10/31/1991CA2039763A1 Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
10/30/1991EP0454580A2 Novel nojirimycin derivatives
10/30/1991EP0454102A2 Essential fatty acid compositions
10/30/1991EP0453692A1 Novel nojirimycin derivatives
10/30/1991EP0453658A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases
10/30/1991CN1014516B Phenyl ethers
10/30/1991CA2041422A1 .alpha.-glycosyl naringin, and its preparation and uses
10/29/1991US5061727 Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
10/29/1991US5061717 Anticholesterol agents
10/29/1991US5061704 Pathologies involving loss of bone tissue
10/29/1991US5061701 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
10/29/1991CA1291484C 6-substituted-4-dialkylaminotetrahydrobenz¬c,d|indoles
10/28/1991WO1991017153A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use
10/28/1991WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
10/28/1991CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
10/28/1991CA2081204A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use
10/24/1991WO1991016067A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
10/24/1991CA2081023A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
10/23/1991EP0453365A1 Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination
10/22/1991US5059696 Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
10/22/1991US5059685 Pretreating natural polysaccharide with acid or alkaline hydroxide, dissolving, suspending in organic solvent, reacting with amine or amino acids, cationization with quaternary ammonium salt
10/22/1991US5059613 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
10/22/1991US5059594 Phytic acid compositions
10/22/1991CA1291143C Hmg-coa reductase inhibitors
10/18/1991CA2078770A1 2(5h)-furanones substituted in the 3 position, as ca2+ channel antagonists and anti-inflammatory agents
10/17/1991WO1991015475A1 Novel vitamin d analogues
10/17/1991WO1991015214A1 Medicament for treating hyperlipidaemia and/or atherosclerosis
10/17/1991WO1991015202A1 Pharmaceutical aqueous solution of 4-[2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid
10/17/1991WO1991015127A1 High-protein high-viscosity alimentary food composition
10/17/1991WO1991013062A3 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
10/17/1991CA2063588A1 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis
10/16/1991EP0451965A1 Processes and intermediates for the preparation of 5-oxygenated HMG-COA reductase inhibitors
10/16/1991EP0451538A2 Use of pyridoindole derivatives in the treatment of ischemic disorders
10/16/1991EP0451486A1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T
10/16/1991EP0451436A2 Method of curing and preventing obesity by alpha-amylase inhibitor
10/16/1991EP0191867B1 Tryciclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
10/16/1991CN1055365A Haloethyl-substituted steroidal enzyme inhibitors
10/16/1991CN1055362A Hydroxymethyl-indolizidines and quinolizidines
10/15/1991US5057509 Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
10/15/1991US5057417 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
10/15/1991CA1290756C Quinazolinone derivative and processes for preparing the same
10/15/1991CA1290691C Methods of treating bone diseases by administration of a cysteine proteinase inhibitor
10/13/1991WO1991016341A1 Peptide derivatives
10/13/1991CA2059302A1 Peptide derivatives
10/11/1991WO1991015507A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991CA2080227A1 Phosphonopeptides with collagenase inhibiting activity
10/10/1991DE4011285A1 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose Medicines for treating hyperlipidemia and / or atherosclerosis
10/10/1991DE4010536A1 Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure A pharmaceutical aqueous solution of 4- (2- (benzenesulfonylamino) ethyl) -phenoxyacetic acid
10/09/1991EP0450812A1 Antihypercholesterolemics
10/09/1991EP0450660A1 Anti-atherosclerotic diaryl compound
10/09/1991EP0450588A1 Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates
10/09/1991EP0450559A1 3-hydroxy derivates of mevinic acid
10/09/1991EP0450515A2 Haloethyl-substituted steroidal enzyme inhibitors
10/09/1991EP0449973A1 Polypeptide-polymer conjugates active in wound healing.
10/09/1991EP0449972A1 Triple stranded nucleic acid and methods of use
10/09/1991EP0449949A1 Use of interleukin-4 for lowering blood-cholesterol levels
10/09/1991EP0449884A1 Derivatives of tetrapeptides as cck agonists
10/09/1991CN1055172A Di-and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
10/08/1991US5055613 Metabolites of pentanedioic acid derivatives
10/08/1991US5055598 Benzopyran derivatives
10/08/1991US5055484 7(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic acids, 7-(1h-pyrrol-3-yl)-substituted 3,5-dihyroxyhept-anoic acids, their corresponding delta-lactones and salts, their use as medicaments and pharmaceutical products and intermediates
10/08/1991US5055480 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
10/08/1991US5055472 Pyrazolopyrimidine type mevalonolactones
10/08/1991US5055451 Prevent tissue damage
10/07/1991WO1991015483A1 An improved process for the preparation of substituted isoflavone derivatives
10/07/1991WO1991015230A1 Ligand for the neu gene product
10/07/1991CA2039985A1 Method of curing and preventing obesity by o-amylase inhibitor
10/06/1991WO1991015491A1 Heterocyclic compounds as aldose reductase inhibitors
10/06/1991WO1991015482A1 Hmg-co a reductive inhibitors
10/06/1991CA2078888A1 Hmg-coa reductase inhibitors
10/06/1991CA2078210A1 Heterocyclic compounds as aldose reductase inhibitors
10/04/1991CA2037877A1 6-alpha hydroxy derivatives of mevinic acids
10/03/1991WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus
10/03/1991WO1991014673A1 Novel process for producing benzoic acid derivative
10/03/1991WO1991014668A1 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
10/03/1991CA2039458A1 Methods for treating interleukin-1 mediated diseases
10/02/1991EP0449728A1 4H-pyrrolo (1,2-a)thieno(2,3-f)(1,4)diazepine derivatives, process for their preparation and pharmaceutical compositions containing them
10/02/1991EP0449562A2 Use of R-Fluoxetine as selective serotonin IC-receptor ligands
10/02/1991EP0449561A2 Use of (R)-norfluoxetine in the preparation of a medicament with affinity to 5HT1c receptors
10/02/1991EP0449405A2 Use of bisphosphonic acids for the treatment of calcium metabolism disorders
10/02/1991EP0449294A1 Hydroxymethyl-indolizidines and quinolizidines
10/02/1991EP0448940A2 Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone
10/02/1991EP0448934A2 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
10/02/1991EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally
10/02/1991EP0448552A1 IMPROVED PROCESS FOR $i(TRANS)-6- 2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS
10/02/1991CN1054978A Novel ascorbic acid derivatives
10/01/1991US5053510 Process for the preparation of polycyclic compounds
10/01/1991US5053419 Administering calcium channel antagonists
10/01/1991CA1290096C Pharmaceutical compositions
10/01/1991CA1289963C All-cis-1,3,5-triamino-2,4,6-cyclohexanetriol derivatives, their use, processes for their preparation and pharmaceutical preparations containing them
10/01/1991CA1289904C Valiolamine derivatives and production thereof
10/01/1991CA1289887C Composition containing gamma-linolenic acid and calcium
10/01/1991CA1289878C Composition for stimulating chondrocytes and osteoblasts (osseinhydroxyapatite compound), method for its production and pharmaceutical products containing said composition
09/1991
09/30/1991CA2039103A1 Improvements in and relating to the selective occupation of serotonin 1c receptors
09/30/1991CA2039102A1 Compounds affecting serotonin receptors
09/28/1991CA2039114A1 4h-pyrrolo[1,2-a]thieno[2,3-f]diazepine[1,4]derivatives, a process for their preparation and pharmaceutical compositions holding same
09/27/1991WO1991014459A1 A bifunctional dtpa-type ligand
09/25/1991EP0448393A1 Antihypercholesterolemics
09/25/1991EP0448253A2 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
1 ... 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 ... 1298